LONG-TERM ADMINISTRATION OF L-ARGININE DID NOT INFLUENCE BLOOD-PRESSURE, HEART-RATE, CARDIAC-HYPERTROPHY OR ARTERIAL-WALL THICKNESS OF SPONTANEOUSLY HYPERTENSIVE RATS

Authors
Citation
F. Kristek, LONG-TERM ADMINISTRATION OF L-ARGININE DID NOT INFLUENCE BLOOD-PRESSURE, HEART-RATE, CARDIAC-HYPERTROPHY OR ARTERIAL-WALL THICKNESS OF SPONTANEOUSLY HYPERTENSIVE RATS, Experimental physiology, 83(5), 1998, pp. 595-603
Citations number
32
Categorie Soggetti
Physiology
Journal title
ISSN journal
09580670
Volume
83
Issue
5
Year of publication
1998
Pages
595 - 603
Database
ISI
SICI code
0958-0670(1998)83:5<595:LAOLDN>2.0.ZU;2-2
Abstract
The aim of this study was to evaluate whether long-term administration of L-arginine, a physiological substrate for the production of nitric oxide, improved blood pressure, heart rate, cardiac hyper trophy and particularly structural changes in the coronary and carotid artery of spontaneously hypertensive rats (SHR). The experiments started with th ree groups of 10-week-old animals: control Wistar rats, untreated SHR and SHR treated with L-arginine (SHR + L-arginine). L-Arginine was adm inistered to SHR in a daily dose of 300 mg kg(-1) intraperitoneally fo r 6 weeks. Blood pressure and heart rate were recorded each week. At t he end of the experiment in one-half of each group heart weight and bo dy weight were determined and the heart weight/body weight index was c alculated. In the other animals, the cardiovascular system was perfuse d via the left ventricle with a glutaraldehyde fixative at 120 mmHg an d the coronary and carotid arteries were processed for transmission el ectron microscopy. The inner diameter and wall thickness (tunica intim a and tunica media) were measured on semithin sections. The reliabilit y of the genetic feature in the SHR group was proved by the increased heart weight, heart weight/body weight index, wall thickness and wall thickness/inner diameter ratio of coronary and carotid arteries in com parison to the group of control Wistar rats. Long-term administration of L-arginine did not significantly influence blood pressure and heart rate in comparison with untreated SHR. Neither were any differences f ound in cardiac hypertrophy or the geometry of the coronary and caroti d arteries (thickness of arterial wall, inner diameter, wall/diameter ratio). In conclusion, the changes in the cardiovascular system in SHR were not reversed, or even alleviated, by chronic treatment with L-ar ginine.